Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07221890 · ClinicalTrials.gov registry record · NA
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
A NA study of Autoimmune Diseases and Rheumatoid Arthritis (RA), sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 1,325
- Enrollment target
- 2
- Study locations
NCT07221890 is a NA study of Autoimmune Diseases and Rheumatoid Arthritis (RA) that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 1,325 participants, above the 925-participant average among 25 other Autoimmune Diseases trials with a reported enrollment target (43% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT07221890, a NA study of Autoimmune Diseases and Rheumatoid Arthritis (RA), is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,325 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this trial is to learn if an interactive evidence-based educational outreach visits to clinicians who prescribe biologics change prescribing of biosimilar medications. The main questions it aims to answer are: 1. Do educational outreach visits lead to a higher number of prescriptions for biosimilar versions of adalimumab? 2. Do in-person or virtual visits work better? Researchers will compare clinicians offered the educational outreach visit to those who are not offered the visit to see if there is a difference in prescribing of biosimilar versions of adalimumab instead of the original brand-name version. Participants will be offered the chance to meet with a trained clinician who will provide educational information tailored to their knowledge and attitudes on the topic. They will also be provided an educational brochure and patient educational materials.
Conditions Studied
Interventions
- OTHER Offered an academic detailing session
- OTHER Standard-of-care outreach from the insurance plan
Study Locations (2)
Kentucky
- Humana Healthcare Research, Inc. - Louisville
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,325 participants |
| Start Date | 2025-11-06 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07221890
The ClinicalTrials.gov registry entry for NCT07221890 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,325 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 925-participant average among 25 other Autoimmune Diseases trials with a reported enrollment target (43% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Autoimmune Diseases appearing as the primary indexed condition, and to 2 interventions - of which Offered an academic detailing session is the first listed.
NCT07221890 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07221890 about?
NCT07221890 is a clinical study titled "A Trial of Academic Detailing to Promote Prescribing of Biosimilars". The goal of this trial is to learn if an interactive evidence-based educational outreach visits to clinicians who prescribe biologics change prescribing of biosimilar medications. The main questions it aims to answer are: 1. Do educational outreach visits lead to a higher number of prescriptions fo...
What is the current status of trial NCT07221890?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,325 participants. The study started on 2025-11-06. Estimated completion is 2027-03-31.
What conditions does trial NCT07221890 study?
This clinical trial studies the following conditions: Autoimmune Diseases, Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD), Psoriasis (PsO).
What interventions are being tested in trial NCT07221890?
The interventions under investigation include: Offered an academic detailing session (OTHER), Standard-of-care outreach from the insurance plan (OTHER).
Who is sponsoring clinical trial NCT07221890?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07221890 being conducted?
This trial has 2 study locations across Kentucky, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autoimmune Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
RECRUITING · NA
-
Testimonials and Navigation in Rheumatology
RECRUITING · NA
-
Day and Night Closed-loop in Young People With Type 1 Diabetes
COMPLETED · NA
-
Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
COMPLETED · NA
-
Rheumatology Diet Study
RECRUITING
-
Collection and Distribution of Biospecimens for Novel Research Uses
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.